tradingkey.logo

Intuitive Surgical Inc

ISRG
507.560USD
+0.010+0.00%
Market hours ETQuotes delayed by 15 min
179.93BMarket Cap
63.43P/E TTM

Intuitive Surgical Inc

507.560
+0.010+0.00%

More Details of Intuitive Surgical Inc Company

Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.

Intuitive Surgical Inc Info

Ticker SymbolISRG
Company nameIntuitive Surgical Inc
IPO dateJun 13, 2000
CEORosa (David J)
Number of employees15638
Security typeOrdinary Share
Fiscal year-endJun 13
Address1020 Kifer Road
CitySUNNYVALE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94086
Phone14085232100
Websitehttps://www.intuitive.com/en-us/about-us/company
Ticker SymbolISRG
IPO dateJun 13, 2000
CEORosa (David J)

Company Executives of Intuitive Surgical Inc

Name
Name/Position
Position
Shareholding
Change
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1000.00%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
228.75K
-5454.00%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
26.16K
--
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
13.01K
+739.00%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
3.11K
+739.00%
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
3.00K
-4731.00%
Dr. Monica P. Reed, M.D.
Dr. Monica P. Reed, M.D.
Independent Director
Independent Director
2.35K
+739.00%
Ms. Sreelakshmi Kolli
Ms. Sreelakshmi Kolli
Independent Director
Independent Director
979.00
+739.00%
Mr. Mark Preston Brosius
Mr. Mark Preston Brosius
Senior Vice President, Chief Manufacturing and Supply Chain Officer
Senior Vice President, Chief Manufacturing and Supply Chain Officer
852.00
-1076.00%
Mr. Lewis Chew
Mr. Lewis Chew
Independent Director
Independent Director
783.00
+739.00%
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1000.00%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
228.75K
-5454.00%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
26.16K
--
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
13.01K
+739.00%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
3.11K
+739.00%
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
3.00K
-4731.00%

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Instruments and accessories
1.52B
60.63%
Systems
590.40M
23.57%
Services
395.90M
15.80%
By RegionUSD
Name
Revenue
Proportion
U.S.
1.72B
68.56%
Outside of United states
787.50M
31.44%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Instruments and accessories
1.52B
60.63%
Systems
590.40M
23.57%
Services
395.90M
15.80%

Shareholding Stats

Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.43%
BlackRock Institutional Trust Company, N.A.
5.33%
State Street Investment Management (US)
4.38%
T. Rowe Price Associates, Inc.
3.46%
Geode Capital Management, L.L.C.
2.33%
Other
75.05%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.43%
BlackRock Institutional Trust Company, N.A.
5.33%
State Street Investment Management (US)
4.38%
T. Rowe Price Associates, Inc.
3.46%
Geode Capital Management, L.L.C.
2.33%
Other
75.05%
Shareholder Types
Shareholders
Proportion
Investment Advisor
49.26%
Investment Advisor/Hedge Fund
27.06%
Hedge Fund
3.07%
Research Firm
2.90%
Pension Fund
2.47%
Bank and Trust
2.40%
Sovereign Wealth Fund
1.44%
Individual Investor
0.51%
Family Office
0.32%
Other
10.58%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
3647
313.93M
88.55%
-8.96M
2025Q3
3649
310.67M
87.63%
-11.36M
2025Q2
3621
320.38M
89.37%
-5.49M
2025Q1
3598
321.67M
89.74%
-4.21M
2024Q4
3426
322.11M
90.31%
-1.17M
2024Q3
3255
319.27M
89.84%
-8.25M
2024Q2
3152
322.86M
91.02%
+572.17K
2024Q1
3116
317.58M
89.60%
-829.16K
2023Q4
3055
314.33M
89.27%
-2.70M
2023Q3
2961
312.82M
89.02%
-3.61M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
33.43M
9.43%
+258.72K
+0.78%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
18.90M
5.33%
-196.41K
-1.03%
Sep 30, 2025
State Street Investment Management (US)
15.54M
4.38%
-12.88K
-0.08%
Sep 30, 2025
T. Rowe Price Associates, Inc.
12.28M
3.46%
-605.75K
-4.70%
Sep 30, 2025
Geode Capital Management, L.L.C.
8.27M
2.33%
+84.99K
+1.04%
Sep 30, 2025
Invesco Capital Management (QQQ Trust)
7.95M
2.24%
+438.98K
+5.84%
Dec 31, 2025
Capital World Investors
7.73M
2.18%
+116.03K
+1.52%
Sep 30, 2025
Fidelity Management & Research Company LLC
4.84M
1.36%
-3.59M
-42.62%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
4.73M
1.33%
+127.12K
+2.76%
Jun 30, 2025
AllianceBernstein L.P.
4.04M
1.14%
-153.40K
-3.66%
Sep 30, 2025
View more

Related ETFs

Updated: Thu, Oct 2
Updated: Thu, Oct 2
Name
Proportion
Langar Global HealthTech ETF
14.08%
iShares U.S. Medical Devices ETF
13.62%
Simplify Health Care ETF
6.65%
First Trust Nasdaq Lux Digi Health Solutions ETF
6.58%
Global X Robotics & Artificial Intelligence ETF
6.53%
Invesco AI and Next Gen Software ETF
5%
Goldman Sachs Future Health Care Equity ETF
4.73%
iShares US Select Equity Active ETF
4.67%
Neuberger Berman Disrupters ETF
4.34%
Fidelity Digital Health ETF
3.66%
View more
Langar Global HealthTech ETF
Proportion14.08%
iShares U.S. Medical Devices ETF
Proportion13.62%
Simplify Health Care ETF
Proportion6.65%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion6.58%
Global X Robotics & Artificial Intelligence ETF
Proportion6.53%
Invesco AI and Next Gen Software ETF
Proportion5%
Goldman Sachs Future Health Care Equity ETF
Proportion4.73%
iShares US Select Equity Active ETF
Proportion4.67%
Neuberger Berman Disrupters ETF
Proportion4.34%
Fidelity Digital Health ETF
Proportion3.66%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Ex-dividend Date
Type
Ratio
Aug 05, 2021
Split
1→3
Date
Ex-dividend Date
Type
Ratio
Aug 05, 2021
Split
1→3
KeyAI